Matthew L. Sherman
2013 - Acceleron Pharma
In 2013, Matthew L. Sherman earned a total compensation of $999.2K as Executive Vice President and Chief Medical Officer at Acceleron Pharma, a 67% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $171,315 |
|---|---|
| Option Awards | $447,239 |
| Salary | $380,662 |
| Total | $999,216 |
Sherman received $447.2K in option awards, accounting for 45% of the total pay in 2013.
Sherman also received $171.3K in non-equity incentive plan and $380.7K in salary.
Rankings
In 2013, Matthew L. Sherman's compensation ranked 6,607th out of 12,286 executives tracked by ExecPay. In other words, Sherman earned more than 46.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,607 out of 12,286 | 46th |
Division Manufacturing | 2,327 out of 4,612 | 50th |
Major group Chemicals And Allied Products | 694 out of 1,466 | 53rd |
Industry group Drugs | 508 out of 1,160 | 56th |
Industry Biological Products, Except Diagnostic Substances | 83 out of 200 | 59th |
Source: SEC filing on April 15, 2016.
Sherman's colleagues
We found four more compensation records of executives who worked with Matthew L. Sherman at Acceleron Pharma in 2013.